ArticleCancer research2011

Dual IGF-1R/InsR inhibitor BMS-754807 synergizes with hormonal agents in treatment of estrogen-dependent breast cancer.

Xiaonan Hou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.